Cite
HARVARD Citation
Velcheti, V. et al. (n.d.). Phase 2 study of lenvatinib in patients with RET fusion-positive adenocarcinoma of the lung. European journal of cancer. pp. S178-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Velcheti, V. et al. (n.d.). Phase 2 study of lenvatinib in patients with RET fusion-positive adenocarcinoma of the lung. European journal of cancer. pp. S178-. [Online].